A placebo-controlled study of pyritinol in dementia.

Cooper AJ, Magnus RV.

Pharmatherapeutica 1980;2(5):317-22

ABSTRACT

A double-blind, placebo-controlled trial was carried out on 40 patients suffering from moderately advanced dementia.  The patients were allocated randomly either pyritinol (800 mg daily) or identical placebo for 3 months. Assessments using a modified Crichton Geriatric Behavioural Rating Scale were made pre-treatment and monthly up to 3 months, and then at follow-up at 6 months.  Patients on pyritinol showed significantly higher levels of improvement than did those on placebo.  Laboratory tests conducted throughout remained within normal limits for both groups.

HOME               to order
1.     pyritinol  and coma
2.     pyritinol  and head injury
3.     pyritinol  and rheumatoid arthritis
4.     pyritinol  and memory
5.     pyritinol  as a free radical scavenger
6.     pyritinol  and dementia
7.     pyritinol  and dementia
8.     pyritinol  and Alzheimer's
9.     pyritinol  stimulation of neutrophils
10.   pyritinol  vs. Hydergine
11.   pyritinol  and phosphatidylserine
12.   pyritinol  and phosphatidylinositol
13.   pyritinol  and dementia
14.   pyritinol  neurochemical studies
15.   pyritinol  mental disorders
16.   pyritinol  learning by Swiss albino mice